Remedy Pharmaceuticals Receives $2,704,222 New Financing

Feed Type
Link
http://www.venturedeal.com/Search/SearchResultTransactionDetail.aspx?TransactionId=6a946d55-fb0a-4b87-91da-c3b40a4844dc&Preview=1
Date
5/23/2012
Company Name
Remedy Pharmaceuticals
Mailing Address
802 6th Avenue New York, NY 10001
Company Description
Remedy Pharmaceuticals, Inc. is a clinical stage company developing small molecule drugs targeting NCCa-ATP channels in acute central nervous system injury including traumatic brain injury, stroke, and spinal cord injury.
Website
http://www.remedypharmaceuticals.com
Transaction Type
Venture Equity
Transaction Amount
$2,704,222
Transaction Round
Undisclosed
Proceeds Purposes
Proceeds purposes were not disclosed. SEC regulatory filing.
M&A Terms
Venture Investor
Undisclosed